TransMedics Group, Inc. Selling, General and Administrative Expense
TransMedics Group, Inc. (TMDX) reported Selling, General and Administrative Expense of $57.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-04
- TransMedics Group, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $57.83M, a 31.17% increase year-over-year.
- TransMedics Group, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $62.98M, a 44.38% increase year-over-year.
- TransMedics Group, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $51.44M, a 9.67% increase year-over-year.
- TransMedics Group, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $46.02M, a 7.87% increase year-over-year.
- TransMedics Group, Inc. selling, general and administrative expense for fiscal 2025 was $185.17M, a 9.82% increase from fiscal 2024.
- TransMedics Group, Inc. selling, general and administrative expense for fiscal 2024 was $168.62M, a 41.04% increase from fiscal 2023.
- TransMedics Group, Inc. selling, general and administrative expense for fiscal 2023 was $119.55M, a 71.04% increase from fiscal 2022.
- TransMedics Group, Inc. selling, general and administrative expense for fiscal 2022 was $69.90M, a 82.58% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $57.83M 10-Q · filed 2026-08-04 | $120.81M 10-Q · filed 2026-08-04 | $172.25M derived: sum of 3 quarters · filed 2026-08-04 | $218.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $62.98M 10-Q · filed 2026-05-05 | $114.42M derived: sum of 2 quarters · filed 2026-05-05 | $160.44M derived: sum of 3 quarters · filed 2026-05-05 | $204.53M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $51.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $97.45M derived: sum of 2 quarters · filed 2026-02-24 | $141.54M derived: sum of 3 quarters · filed 2026-08-04 | $185.17M 10-K · filed 2026-02-24 |
| 2025-09-30 | $46.02M 10-Q · filed 2025-10-29 | $90.10M derived: sum of 2 quarters · filed 2026-08-04 | $133.73M 10-Q · filed 2025-10-29 | $180.63M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $44.09M 10-Q · filed 2026-08-04 | $87.71M 10-Q · filed 2026-08-04 | $134.62M derived: sum of 3 quarters · filed 2026-08-04 | $177.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $43.63M 10-Q · filed 2026-05-05 | $90.53M derived: sum of 2 quarters · filed 2026-05-05 | $133.19M derived: sum of 3 quarters · filed 2026-05-05 | $176.08M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $46.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $89.56M derived: sum of 2 quarters · filed 2026-02-24 | $132.46M derived: sum of 3 quarters · filed 2026-02-24 | $168.62M 10-K · filed 2026-02-24 |
| 2024-09-30 | $42.66M 10-Q · filed 2025-10-29 | $85.55M derived: sum of 2 quarters · filed 2025-10-29 | $121.71M 10-Q · filed 2025-10-29 | $156.27M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $42.90M 10-Q · filed 2025-07-30 | $79.06M 10-Q · filed 2025-07-30 | $113.62M derived: sum of 3 quarters · filed 2026-02-24 | $144.27M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $36.16M 10-Q · filed 2025-05-08 | $70.72M derived: sum of 2 quarters · filed 2026-02-24 | $101.37M derived: sum of 3 quarters · filed 2026-02-24 | $130.73M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $34.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $65.21M derived: sum of 2 quarters · filed 2026-02-24 | $94.57M derived: sum of 3 quarters · filed 2026-02-24 | $119.55M 10-K · filed 2026-02-24 |
| 2023-09-30 | $30.65M 10-Q · filed 2024-10-29 | $60.01M derived: sum of 2 quarters · filed 2024-10-29 | $84.99M 10-Q · filed 2024-10-29 | $106.72M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $29.36M 10-Q · filed 2024-08-01 | $54.34M 10-Q · filed 2024-08-01 | $76.07M derived: sum of 3 quarters · filed 2025-02-27 | $92.92M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $24.98M 10-Q · filed 2024-05-02 | $46.71M derived: sum of 2 quarters · filed 2025-02-27 | $63.56M derived: sum of 3 quarters · filed 2025-02-27 | $80.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $21.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $38.58M derived: sum of 2 quarters · filed 2025-02-27 | $55.96M derived: sum of 3 quarters · filed 2025-02-27 | $69.90M 10-K · filed 2025-02-27 |
| 2022-09-30 | $16.85M 10-Q · filed 2023-11-08 | $34.23M derived: sum of 2 quarters · filed 2023-11-08 | $48.17M 10-Q · filed 2023-11-08 | $60.17M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $17.38M 10-Q · filed 2023-08-04 | $31.32M 10-Q · filed 2023-08-04 | $43.32M derived: sum of 3 quarters · filed 2024-02-27 | $53.66M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $13.94M 10-Q · filed 2023-05-04 | $25.94M derived: sum of 2 quarters · filed 2024-02-27 | $36.27M derived: sum of 3 quarters · filed 2024-02-27 | $45.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $22.34M derived: sum of 2 quarters · filed 2024-02-27 | $31.50M derived: sum of 3 quarters · filed 2024-02-27 | $38.28M 10-K · filed 2024-02-27 |
| 2021-09-30 | $10.34M 10-Q · filed 2022-11-04 | $19.50M derived: sum of 2 quarters · filed 2022-11-04 | $26.28M 10-Q · filed 2022-11-04 | $32.46M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $9.16M 10-Q · filed 2022-08-03 | $15.95M 10-Q · filed 2022-08-03 | $22.12M derived: sum of 3 quarters · filed 2023-02-27 | $27.62M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $6.79M 10-Q · filed 2022-05-05 | $12.96M derived: sum of 2 quarters · filed 2023-02-27 | $18.45M derived: sum of 3 quarters · filed 2023-02-27 | $24.32M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $11.67M derived: sum of 2 quarters · filed 2023-02-27 | $17.54M derived: sum of 3 quarters · filed 2023-02-27 | $24.19M 10-K · filed 2021-03-11 |
| 2020-09-30 | $5.49M 10-Q · filed 2021-11-09 | $11.36M derived: sum of 2 quarters · filed 2021-11-09 | $18.01M 10-Q · filed 2021-11-09 | $24.18M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $5.87M 10-Q · filed 2021-08-06 | $12.52M 10-Q · filed 2021-08-06 | $18.69M derived: sum of 3 quarters · filed 2021-08-06 | $25.21M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $6.65M 10-Q · filed 2021-05-07 | $12.82M derived: sum of 2 quarters · filed 2021-05-07 | $19.34M derived: sum of 3 quarters · filed 2021-05-07 | $25.59M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $12.69M derived: sum of 2 quarters · filed 2021-03-11 | $18.94M derived: sum of 3 quarters · filed 2021-03-11 | $23.60M 10-K · filed 2021-03-11 |
| 2019-09-28 | $6.52M 10-Q · filed 2020-11-06 | $12.77M derived: sum of 2 quarters · filed 2020-11-06 | $17.42M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $6.25M 10-Q · filed 2020-08-07 | $10.90M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $4.65M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $12.31M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $2.80M 10-Q · filed 2019-11-08 | $5.70M derived: sum of 2 quarters · filed 2019-11-08 | $7.94M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $2.90M 10-Q · filed 2019-08-08 | $5.14M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $2.24M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |